Item 8.01 Other Events.

On October 30, 2020, Pfizer Inc. ("Pfizer") issued a press release announcing receipt of all required antitrust approvals and other details relating to the anticipated closing of the proposed spin-off of Pfizer's global, primarily off-patent branded and generic established medicines business (the "Upjohn Business") and the subsequent proposed combination of the Upjohn Business with Mylan N.V. A copy of the press release is attached hereto as Exhibit 99.1.

Item 9.01 Financial Statements and Exhibits




(d) Exhibits



99.1      Press Release, dated October 30, 2020

104     Cover Page Interactive Data File-The cover page XBRL tags are embedded
        within the Inline XBRL Document

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses